CELL LUNG-CANCER
Single nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancer
... Abstract: Lung cancer is a major public health problem throughout the ...frequent cancer types (prostate, breast, colorectal, stomach, lung), lung cancer is the leading cause of ...
14
FePt/GO Nanosheets Suppress Proliferation, Enhance Radiosensitization and Induce Autophagy of Human Non-Small Cell Lung Cancer Cells
... various cancer and normal cells was evaluated by cell counting kit-8 assay, and their effects on radiosensitization were determined by colony formation ...of cancer cells, but also increased their ...
11
Anterior Mediastinal Mass in a Young Marijuana Smoker: A Rare Case of Small-Cell Lung Cancer
... lung cancer. In the United States, there have been 0.03 cases per 1000 of lung cancer reported in patients younger than 39 ...of lung cancer by ...
5
An adherent subline of a unique small cell lung cancer cell line downregulates antigens of the neural cell adhesion molecule
... Small-cell lung cancer (SCLC) lines are distinguished from non-small-cell lung cancer (NSCLC) lines by their growth in floating aggregates, in contrast to the adherent monolayers ...
8
Non-small cell to small cell lung cancer on PD-1 inhibitors: two cases on potential histologic transformation
... non-small cell lung cancer (NSCLC) to small cell lung cancer (SCLC) is a well-recognized mechanism of resistance in EGFR-mutant adeno- carcinoma upon treatment with TKIs, but ...
6
Elevated expression of podoplanin and its clinicopathological, prognostic, and therapeutic values in squamous non-small cell lung cancer
... In the current study, PDPN protein level in the deriva- tion cohort was interrogated via immunohistochemistry in 70 SqNSCLC patients. In the validation cohort from TCGA data set, PDPN expression was examined on the mRNA ...
12
Scriptaid overcomes hypoxia-induced cisplatin resistance in both wild-type and mutant p53 lung cancer cells
... Non-small cell lung cancer (NSCLC), comprising 85% of lung cancer cases, has been associated with resistance to ...in lung cancer cells with stabilized hypoxia inducible ...
15
Pathological transition as the arising mechanism for drug resistance in lung cancer
... small cell lung cancer; NSCLC: non-small cell lung cancer; ADC: adenocarcinoma; SCC: squamous cell carcinoma; LCC: large cell carcinoma; TTF1: thyroid transcription ...
13
Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo
... non-small cell lung cancer; (SCLC): small cell lung cancer; (TQ): Thymoquinone; (EAC): Ehrlic ascites sarcoma; (CDDP): Cisplatin; (PLKs): Polo like kinases; (ATCC): American type ...
11
17α-Ethynylestradiol and 4-Nonylphenol Stimulate Lung Adenocarcinoma Cells Production in Xenoestrogenic Way
... 1. Wang, S.; Sun, T.; Sun, H.; Li, X.; Li, J.; Zheng, X.; Mallampati, S.; Sun, H.; Zhou, X.; Zhou, C., et al. Survival improvement in patients with non-small cell lung cancer between 1983 and 2012: ...
31
BIOSYNTHETIC PATHWAY AND MOLECULAR DOCKING OF METHYL ISOCYANATE (MIC) - p53 INTERACTION STUDY
... many cancer causing pathways in humans. Some of them include prostate cancer, small cell lung cancer, bladder cancer and Huntington’s disease found in victims of Bhopal Gas ...
20
ZAR1 is a novel epigenetically inactivated tumour suppressor in lung cancer
... various lung cancer cell lines as A427, A549 and H322, HTB171 and also in HeLa cervix cancer ...H358 lung cancer cells however expressed ZAR1 ...the lung (set 100%), but ...
12
Identification of lipid-phosphatidylserine (PS) as the target of unbiasedly selected cancer specific peptide-peptoid hybrid PPS1
... HCC4017 lung cancer cells but not normal HBEC epithelial cells ...other lung cancer cell lines and the activity profile of PPS1D1 on those cell ...of lung cancer ...
13
Superior vena cava syndrome in a patient with locally advanced lung cancer with good response to definitive chemoradiation: a case report
... Case presentation: Our patient was a 51-year-old black woman with locally advanced, stage IIIB non-small cell lung cancer who had no clinical symptoms of superior vena cava syndrome at the time of ...
6
Investigation of myositis and scleroderma specific autoantibodies in patients with lung cancer
... right paratracheal, prevascular, subcarinal and right hilar regions. The CT scan showed no evidence of interstitial lung disease. Histological analysis confirmed poorly dif- ferentiated adenocarcinoma. ...
5
Original Article The identification of genes associated with NSCLC prognosis based on an integrated bioinformatics analysis
... “non-small cell lung cancer”, and the can- cer type was non-small cell lung cancer (adenocarcinoma of the lung and squamous cell lung carcinoma); the data ...
8
Diabetes insipidus and panhypopituitarism as a first presentation of silent adenocarcinoma of lung: a case report and literature review
... advanced cancer and associated with widespread metasta- ses, typically affecting elderly patients, especially those aged 60–70 years ...and lung are the most common sites of the primary tumor, accounting ...
7
Characteristics and outcome of patients with newly diagnosed advanced or metastatic lung cancer admitted to intensive care units (ICUs)
... with lung cancer within 1 month and had a good performance status before ICU admission, the possibility of cancer treatment after complications leading to ICU admission could be small ...non-small ...
9
Nitrilase 1 modulates lung tumor progression in vitro and in vivo
... the highest homology to animal and bacterial nitrilases. It was found that in plants, Nit1 is required to repress proliferation and in its absence causes cells to become polyploidy due to defects that occur in ...
12
Original Article The effect of curcumin on the apoptosis of lung cancer cells by regulating DJ-1-PTEN/PI3K/AKT signaling
... reducing cell apoptosis, pro- moting cell proliferation, and regulating survival and progression ...regulates cell proliferation, apoptosis, migration, and invasion to play an anti-tumor effect [11, ...
7